Diffusion-weighted magnetic resonance imaging in early central retinal artery occlusion.
Eye
central retinal artery occlusion
diffusion-weighted imaging
ischemic stroke
magnetic resonance imaging
sudden visual loss
Journal
European stroke journal
ISSN: 2396-9881
Titre abrégé: Eur Stroke J
Pays: England
ID NLM: 101688446
Informations de publication
Date de publication:
Dec 2023
Dec 2023
Historique:
medline:
27
11
2023
pubmed:
24
11
2023
entrez:
24
11
2023
Statut:
ppublish
Résumé
Restricted retinal diffusion (RDR) has recently been recognized as a frequent finding on standard diffusion-weighted imaging (DWI) in central retinal artery occlusion (CRAO). However, data on early DWI signal evolution are missing. Consecutive CRAO patients with DWI performed within 24 h after onset of visual impairment were included in a bicentric, retrospective cross-sectional study. Two blinded neuroradiologists assessed randomized DWI scans for the presence of retinal ischemia. RDR detection rates, false positive ratings, and interrater agreement were evaluated for predefined time groups. Sixty eight CRAO patients (68.4 ± 16.8 years; 25 female) with 72 DWI scans (76.4% 3 T, 23.6% 1.5 T) were included. Mean time-delay between onset of CRAO and DWI acquisition was 13.4 ± 7.0 h. Overall RDR detection rates ranged from 52.8% to 62.5% with false positive ratings in 4.2%-8.3% of cases. RDR detection rates were higher in DWI performed 12-24 h after onset, when compared with DWI acquired within the first 12 h (79.5%vs 39.3%, DWI-based detection of retinal ischemia in early CRAO is likely to be time-dependent with superior diagnostic accuracy for DWI performed 12-24 h after onset of visual impairment.
Identifiants
pubmed: 37997381
doi: 10.1177/23969873231190716
pmc: PMC10683725
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
974-981Déclaration de conflit d'intérêts
Declaration of conflicting interestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Références
Semin Ophthalmol. 2010 Sep-Nov;25(5-6):225-32
pubmed: 21091004
Am J Ophthalmol. 2015 Apr;159(4):667-76
pubmed: 25579642
N Engl J Med. 2018 Aug 16;379(7):611-622
pubmed: 29766770
Retina. 2007 Mar;27(3):276-89
pubmed: 17460582
Retina. 2013 Nov-Dec;33(10):2110-7
pubmed: 23594722
Clin Neuroradiol. 2022 Dec;32(4):1037-1044
pubmed: 35503466
JAMA Neurol. 2015 Oct;72(10):1148-54
pubmed: 26258861
Acta Ophthalmol. 2020 Sep;98(6):e680-e684
pubmed: 32040258
Eur J Med Res. 2006 Jun 30;11(6):250-2
pubmed: 16820338
Retina. 2006 Jan;26(1):110-2
pubmed: 16395151
J Stroke Cerebrovasc Dis. 2022 Sep;31(9):106644
pubmed: 35849917
AJNR Am J Neuroradiol. 2021 Sep;42(9):1661-1666
pubmed: 34266868
Acta Ophthalmol. 2021 Mar;99(2):e247-e252
pubmed: 32767551
Ophthalmologe. 2021 Nov;118(11):1107-1112
pubmed: 34351478
Ann Neurol. 2018 May;83(5):980-993
pubmed: 29689135
Acta Radiol. 2017 Dec;58(12):1457-1467
pubmed: 28330373
Stroke. 2020 Jul;51(7):2018-2025
pubmed: 32568646
Sci Rep. 2021 Oct 15;11(1):20538
pubmed: 34654843
BMC Med Imaging. 2020 Apr 19;20(1):40
pubmed: 32306913
Neuroradiology. 2018 Sep;60(9):903-912
pubmed: 30022231
Life (Basel). 2022 Aug 22;12(8):
pubmed: 36013458
Arthritis Rheum. 1990 Aug;33(8):1122-8
pubmed: 2202311
Clin Neuroradiol. 2021 Sep;31(3):619-626
pubmed: 32936308
Am J Ophthalmol. 2005 Sep;140(3):376-91
pubmed: 16138997